Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates.
Gielen GH, Baugh JN, van Vuurden DG, Veldhuijzen van Zanten SEM, Hargrave D, Massimino M, Biassoni V, Morales la Madrid A, Karremann M, Wiese M, Thomale U, Janssens GO, von Bueren AO, Perwein T, Nussbaumer G, Hoving EW, Niehusmann P, Gessi M, Kwiecien R, Bailey S, Pietsch T, Andreiuolo F, Kramm CM. Gielen GH, et al. Among authors: nussbaumer g. Neurooncol Adv. 2022 May 20;4(1):vdac077. doi: 10.1093/noajnl/vdac077. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35733513 Free PMC article.
Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential.
Wiese M, Pohlmeier B, Kubiak K, El-Khouly FE, Sitte M, Carcaboso AM, Baugh JN, Perwein T, Nussbaumer G, Karremann M, Gielen GH, Salinas G, Kramm CM. Wiese M, et al. Among authors: nussbaumer g. J Tradit Complement Med. 2023 Jul 25;14(1):101-108. doi: 10.1016/j.jtcme.2023.07.007. eCollection 2024 Jan. J Tradit Complement Med. 2023. PMID: 38223806 Free PMC article.
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent MRI lesions after first-line treatment.
Obrecht-Sturm D, Schömig L, Mynarek M, Bison B, Schwarz R, Pietsch T, Pfister SM, Sill M, Sturm D, Sahm F, Kortmann RD, Gerber NU, von Bueren AO, Fleischhack G, Schüller U, Nussbaumer G, Benesch M, Rutkowski S. Obrecht-Sturm D, et al. Among authors: nussbaumer g. Neuro Oncol. 2024 Apr 5:noae071. doi: 10.1093/neuonc/noae071. Online ahead of print. Neuro Oncol. 2024. PMID: 38578306
Cystinosis with sclerotic bone lesions.
Sirrs S, Munk P, Mallinson PI, Ouellette H, Horvath G, Cooper S, Da Roza G, Rosenbaum D, O'Riley M, Nussbaumer G, Hoang LN, Lee CH. Sirrs S, et al. Among authors: nussbaumer g. JIMD Rep. 2014;13:27-31. doi: 10.1007/8904_2013_256. Epub 2013 Oct 6. JIMD Rep. 2014. PMID: 24097416 Free PMC article.
11 results